CSL is a global biotechnology company headquartered in Denver, CO, with a focus on delivering innovative therapies and vaccines to patients worldwide. With its businesses including CSL Behring, CSL Seqirus, and CSL Vifor, the company offers a broad range of quality plasma-derived and recombinant therapies, as well as being one of the world's largest providers of influenza vaccines.
Driven by a commitment to patient health and public well-being, CSL's core values of innovation and sustainability guide its operations. The company's research and development capabilities span plasma protein technology, recombinant technology, cell and gene therapy, and vaccines technology, while its sustainability efforts aim to create a more sustainable future through responsible environmental practices, a resilient supply chain, and a positive working environment for its diverse and inclusive workforce.
Generated from the website